MedTrace Logo

Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls

NCT03029962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 948

Last updated 2021-03-16

No results posted yet for this study

Summary

The purpose of this study is to finalize and rigorously evaluate Girl2Girl, a novel text messaging-based teenage pregnancy prevention (TPP) program designed specifically for LGB women ages 14-18 years, nation-wide. The guiding theoretical model is the Information-Motivation-Behavioral Skills (IMB) Model, which has been used extensively and is associated with increases in TPP behavior.

Conditions

  • Teenage Pregnancy

Interventions

BEHAVIORAL

Girl2Girl

Girl2Girl is a text messaging-based teenage pregnancy prevention program specifically for 14-18 year old LGB adolescent females. Content is guided by the Information-Motivation-Behavioral Skills (IMB) model and focuses on: HIV information, motivations to engage in HIV preventive behavior, communication skills, behavioral skills (e.g., using a condom; HIV testing); and healthy/unhealthy relationships. Behavioral skills content is reinforced using brief online videos. The intervention is 7 weeks long. A "booster" is delivered 12-weeks post-intervention end and reviews the topics covered in the intervention. Girl2Girl content is tailored based upon sexual experience (i.e., whether one is abstinent or sexually active) and whether one is same-sex or dually attracted.

Sponsors & Collaborators

  • The Office of Adolescent Health, HHS

    collaborator FED

  • University of British Columbia

    collaborator OTHER

  • City University of New York

    collaborator OTHER

  • Center for Innovative Public Health Research

    lead OTHER

Principal Investigators

  • Michele L Ybarra, PhD · Center for Innovative Public Health Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2020-01-12
Completion
2020-01-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03029962 on ClinicalTrials.gov